Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation (Q78056590)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

7

T F Lüscher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

Z Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

P Birkenhauer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

F Julmy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

D Chickering

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

J P Ranieri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

H P Merkle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

B Gander

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

Journal of Controlled Release

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

269-277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

The pathogenesis of atherosclerosis: a perspective for the 1990s

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

The intima. Soil for atherosclerosis and restenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Antithrombin III inhibits thrombin-induced proliferation in human arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Different Effects of Thrombin Receptor Activation on Endothelium and Smooth Muscle Cells of Human Coronary Bypass Vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Heparin immobilized on proteins usable for arterial prosthesis coating: growth inhibition of smooth-muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Local drug delivery for the prevention of restenosis. Fact, fancy, and future

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Local and systemic delivery of low molecular weight heparin stimulates the reendothelialization after balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Biodegradable long-circulating polymeric nanospheres

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Biologically erodable microspheres as potential oral drug delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Controlled delivery of therapeutics from microporous membranes. II. In vitro degradation and release of heparin-loaded poly(D,L-lactide-co-glycolide)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Suppression by heparin of smooth muscle cell proliferation in injured arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Hunting for animal alternatives

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

The separation of active and inactive forms of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Implications of pulsatile stretch on growth of saphenous vein and mammary artery smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Protein kinase C alpha expression is required for heparin inhibition of rat smooth muscle cell proliferation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Differentiation of vascular smooth muscle cells and the regulation of protein kinase C-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Integrin-induced protein kinase Calpha and Cepsilon translocation to focal adhesions mediates vascular smooth muscle cell spreading

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Angiographic follow-up after placement of a self-expanding coronary-artery stent

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, E

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Abnormal growth regulation of vascular smooth muscle cells by heparin in patients with restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Intracoronary heparin delivery in humans. Acute feasibility and long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900078-4

7 January 2021

10.1016/S0168-3659(99)00078-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10425332%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference